{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "2264", "geneName": "FGFR4", "geneLongName": "FIBROBLAST GROWTH FACTOR RECEPTOR 4", "entrezId": 2264, "geneCategories": [{"id": "4c14ec3171544bd2b18b2f1a45e6c8f2", "name": "KINASE"}, {"id": "6c528ef943614261afc5e4f52a3c60ee", "name": "TYROSINE KINASE"}, {"id": "655bedfa9d71482796a5a34b87dfb297", "name": "DRUG RESISTANCE"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}, {"id": "4866b8ad-3c3e-4c04-802f-587f697212db", "name": "ENZYME"}], "interactions": [{"interactionId": "840c22b6-0359-44a9-8250-14a0e78957d2", "interactionTypes": [], "drugName": "EVEROLIMUS", "drugConceptId": "chembl:CHEMBL1908360", "sources": ["PharmGKB"], "pmids": [], "score": 0.06}, {"interactionId": "ee83d527-7583-4a46-b97c-ac59e09ab86c", "interactionTypes": ["inhibitor"], "drugName": "HESPERADIN", "drugConceptId": "chembl:CHEMBL514409", "sources": ["DTC"], "pmids": [19035792], "score": 0.06}, {"interactionId": "a726c760-5196-426d-8989-2e0dfa31fc09", "interactionTypes": [], "drugName": "TRAFERMIN", "drugConceptId": "chembl:CHEMBL2108081", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.59}, {"interactionId": "343c88c0-fbb2-4f5b-8dde-7a8cd25ed53c", "interactionTypes": ["inhibitor"], "drugName": "ORANTINIB", "drugConceptId": "chembl:CHEMBL274654", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "dbfd2ee9-92b7-4861-8ca4-1780910a41bf", "interactionTypes": ["inhibitor"], "drugName": "ENMD-981693", "drugConceptId": "chembl:CHEMBL52885", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "d0e942de-3ee9-458f-8dbf-b2f69d1a622d", "interactionTypes": ["inhibitor"], "drugName": "FGF401", "drugConceptId": "chembl:CHEMBL3545293", "sources": ["ChemblInteractions"], "pmids": [], "score": 2.38}, {"interactionId": "9e0928fb-1b38-4728-88f3-1a852a15c818", "interactionTypes": [], "drugName": "ENMD-2076", "drugConceptId": "chembl:CHEMBL482968", "sources": ["ClearityFoundationClinicalTrial"], "pmids": [], "score": 0.1}, {"interactionId": "12662db9-70d3-4481-bc07-b6d814f95ea1", "interactionTypes": ["inhibitor"], "drugName": "XL-999", "drugConceptId": "chembl:CHEMBL3545285", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.22}, {"interactionId": "e87cdec9-6663-4d49-b712-30f2b344007f", "interactionTypes": [], "drugName": "FP-1039", "drugConceptId": "chembl:CHEMBL4297755", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.48}, {"interactionId": "f9b3fddc-ce84-47ab-9eec-1ced9aaddfa1", "interactionTypes": [], "drugName": "METHOTREXATE", "drugConceptId": "chembl:CHEMBL34259", "sources": ["PharmGKB"], "pmids": [16822847], "score": 0.04}, {"interactionId": "ef2f0132-c7cb-4ece-b9f1-fe7ca096d619", "interactionTypes": ["inhibitor"], "drugName": "DERAZANTINIB", "drugConceptId": "chembl:CHEMBL4297187", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.59}, {"interactionId": "5d4dd64e-b598-4aa1-bb80-7840181f6ba3", "interactionTypes": [], "drugName": "CYCLOPHOSPHAMIDE", "drugConceptId": "chembl:CHEMBL88", "sources": ["PharmGKB"], "pmids": [16822847], "score": 0.06}, {"interactionId": "514a551d-e0ae-478b-af5a-bd9f6ca679cc", "interactionTypes": ["inhibitor"], "drugName": "BRIVANIB", "drugConceptId": "chembl:CHEMBL377300", "sources": ["ChemblInteractions", "PharmGKB"], "pmids": [20124951], "score": 0.65}, {"interactionId": "7145a789-0708-499d-ac10-1114f4ae8f85", "interactionTypes": ["inhibitor"], "drugName": "BRIVANIB ALANINATE", "drugConceptId": "chembl:CHEMBL270995", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.34}, {"interactionId": "1a6f100c-ce7d-436b-bb10-f4be4c012a6a", "interactionTypes": ["inhibitor"], "drugName": "CP-459632", "drugConceptId": "chembl:CHEMBL3545300", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.3}, {"interactionId": "3444ff34-0427-4f75-a853-7d1347aaf3ac", "interactionTypes": ["inhibitor"], "drugName": "AZD-4547", "drugConceptId": "chembl:CHEMBL3184679", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.59}, {"interactionId": "1dc15a66-50c1-4176-b80b-48ccb5efe07f", "interactionTypes": ["inhibitor"], "drugName": "NINTEDANIB", "drugConceptId": "chembl:CHEMBL502835", "sources": ["ClearityFoundationClinicalTrial"], "pmids": [], "score": 0.11}, {"interactionId": "df14f649-a51b-4e1d-ab3d-edd88bd56e77", "interactionTypes": [], "drugName": "ERLOTINIB", "drugConceptId": "chembl:CHEMBL553", "sources": ["CIViC"], "pmids": [31027687], "score": 0.1}, {"interactionId": "faed7196-5869-4131-916f-58ed0cf9b68e", "interactionTypes": [], "drugName": "FLUOROURACIL", "drugConceptId": "chembl:CHEMBL185", "sources": ["PharmGKB"], "pmids": [16822847], "score": 0.05}, {"interactionId": "5b881c36-f038-4f3a-b370-1086e7d19c0c", "interactionTypes": ["inhibitor"], "drugName": "INFIGRATINIB", "drugConceptId": "chembl:CHEMBL1852688", "sources": ["ChemblInteractions", "CancerCommons"], "pmids": [], "score": 0.22}, {"interactionId": "b2551a7d-1116-4621-a9e8-7f2767413c8f", "interactionTypes": [], "drugName": "PALIFERMIN", "drugConceptId": "chembl:CHEMBL1201821", "sources": ["TdgClinicalTrial", "TEND"], "pmids": [11149756, 9755102, 10950949, 7526860, 9843417], "score": 2.77}, {"interactionId": "7925dfe6-4d5c-41bc-9b02-3411c5dfd027", "interactionTypes": ["inhibitor"], "drugName": "PONATINIB", "drugConceptId": "chembl:CHEMBL1171837", "sources": ["CIViC"], "pmids": [24124571, 23468082], "score": 0.32}, {"interactionId": "ef4136a3-aef0-4c17-a982-1d69471eb539", "interactionTypes": ["inhibitor"], "drugName": "ROGARATINIB", "drugConceptId": "chembl:CHEMBL3963485", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.48}, {"interactionId": "8b1ea04f-29d0-4342-afa1-647045cc87b8", "interactionTypes": ["inhibitor"], "drugName": "NINTEDANIB ESYLATE", "drugConceptId": "chembl:CHEMBL3039504", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.26}, {"interactionId": "5c98cc0c-a853-47b1-9525-b364ca1f1ce5", "interactionTypes": [], "drugName": "DOVITINIB", "drugConceptId": "chembl:CHEMBL522892", "sources": ["ClearityFoundationClinicalTrial", "CIViC"], "pmids": [24124571], "score": 0.08}, {"interactionId": "9cac5af9-bc27-4732-8c48-919ea85b6c79", "interactionTypes": ["inhibitor"], "drugName": "LY-2874455", "drugConceptId": "chembl:CHEMBL3545264", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.59}]}, {"searchTerm": "2264", "geneName": "COX17", "geneLongName": "COX17, CYTOCHROME C OXIDASE COPPER CHAPERONE", "entrezId": 10063, "geneCategories": [], "interactions": []}], "unmatchedTerms": []}